問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
盧菁華
下載
2024-07-01 - 2026-12-31
Condition/Disease
-
Test Drug
Participate Sites3Sites
Recruiting3Sites
2025-02-01 - 2027-12-31
● Evaluate the safety and tolerability of DNTH103 in patients with generalized myasthenia gravis (gMG) up to week 13.
DNTH103 150 mg/mL
Participate Sites8Sites
Recruiting8Sites
2020-12-01 - 2022-11-30
Recruiting2Sites
Terminated1Sites
2021-02-01 - 2027-12-31
Participate Sites6Sites
Recruiting6Sites
2025-09-15 - 2030-12-31
2024-12-01 - 2028-01-31
Participate Sites5Sites
Recruiting5Sites
2024-03-01 - 2027-06-30
Not yet recruiting1Sites
Recruiting4Sites
2021-07-14 - 2029-05-31
Participate Sites4Sites
2022-02-01 - 2027-12-31
2022-12-01 - 2028-12-31
Participate Sites1Sites
Recruiting1Sites
全部
